| Code | 0716F | ||||||||||
| MA number | 15/0222/25-S | ||||||||||
| Product Form: | plo ijf 10x1 g (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | hameln pharma gmbh, Germany | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.08.2025 |
| Validity: | 14.08.2030 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Cefotaxime hameln_07.2025.pdf
|
| PIL: |
PIL_Cefotaxime hameln_07.2025.pdf
|
| Safety feature | Yes |
| Data update: | 20.08.2025 |
